BACKGROUND: Although early survival from sepsis has improved with timely resuscitation and source control, survivors frequently experience persistent inflammation and develop chronic critical illness. We examined whether increased copy number of endogenous alarmins, mitochondrial DNA, and nuclear DNA are associated with the early "genomic storm" in blood leukocytes and the development of chronic critical illness in hospitalized patients with surgical sepsis. METHODS: A prospective, observational, cohort study of critically ill septic patients was performed at a United States tertiary health care center. Blood samples were obtained at multiple time points after the onset of sepsis. Droplet Digital polymerase chain reaction (Bio-Rad Laboratories, Hercules, CA) was performed to quantify RHO (nuclear DNA) and MT-CO2 (mitochondrial DNA) copies in plasma. Leukocyte transcriptomic expression of 63 genes was also measured in whole blood. RESULTS: We enrolled 112 patients with surgical sepsis. Two experienced early death, 69 recovered rapidly, and 41 developed chronic critical illness. Both mitochondrial DNA and nuclear DNA copy number were increased in all sepsis survivors, but early nuclear DNA, and not mitochondrial DNA, copy number was further increased in patients who developed chronic critical illness. Cell-free DNA copy number was associated with in-hospital but not long-term (180-day and 365-day) mortality and were only weakly correlated with leukocyte transcriptomics. CONCLUSION: Increased cell-free DNA copy number persists in survivors of sepsis but is not strongly associated with leukocyte transcriptomics. Nuclear DNA but not mitochondrial DNA copy number is associated with adverse, short-term, clinical trajectories and outcomes.
BACKGROUND: Although early survival from sepsis has improved with timely resuscitation and source control, survivors frequently experience persistent inflammation and develop chronic critical illness. We examined whether increased copy number of endogenous alarmins, mitochondrial DNA, and nuclear DNA are associated with the early "genomic storm" in blood leukocytes and the development of chronic critical illness in hospitalized patients with surgical sepsis. METHODS: A prospective, observational, cohort study of critically ill septicpatients was performed at a United States tertiary health care center. Blood samples were obtained at multiple time points after the onset of sepsis. Droplet Digital polymerase chain reaction (Bio-Rad Laboratories, Hercules, CA) was performed to quantify RHO (nuclear DNA) and MT-CO2 (mitochondrial DNA) copies in plasma. Leukocyte transcriptomic expression of 63 genes was also measured in whole blood. RESULTS: We enrolled 112 patients with surgical sepsis. Two experienced early death, 69 recovered rapidly, and 41 developed chronic critical illness. Both mitochondrial DNA and nuclear DNA copy number were increased in all sepsis survivors, but early nuclear DNA, and not mitochondrial DNA, copy number was further increased in patients who developed chronic critical illness. Cell-free DNA copy number was associated with in-hospital but not long-term (180-day and 365-day) mortality and were only weakly correlated with leukocyte transcriptomics. CONCLUSION: Increased cell-free DNA copy number persists in survivors of sepsis but is not strongly associated with leukocyte transcriptomics. Nuclear DNA but not mitochondrial DNA copy number is associated with adverse, short-term, clinical trajectories and outcomes.
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: Marcel P B Jansen; Wilco P Pulskens; Loes M Butter; Sandrine Florquin; Nicole P Juffermans; Joris J T H Roelofs; Jaklien C Leemans Journal: Shock Date: 2018-03 Impact factor: 3.454
Authors: Peter Hampson; Robert J Dinsdale; Christopher M Wearn; Amy L Bamford; Jonathan R B Bishop; Jon Hazeldine; Naiem S Moiemen; Paul Harrison; Janet M Lord Journal: Ann Surg Date: 2017-06 Impact factor: 12.969
Authors: Alex G Cuenca; Lori F Gentile; M Cecilia Lopez; Ricardo Ungaro; Huazhi Liu; Wenzhong Xiao; Junhee Seok; Michael N Mindrinos; Darwin Ang; Tezcan Ozrazgat Baslanti; Azra Bihorac; Philip A Efron; Joseph Cuschieri; H Shaw Warren; Ronald G Tompkins; Ronald V Maier; Henry V Baker; Lyle L Moldawer Journal: Crit Care Med Date: 2013-05 Impact factor: 7.598
Authors: Chanu Rhee; Raymund Dantes; Lauren Epstein; David J Murphy; Christopher W Seymour; Theodore J Iwashyna; Sameer S Kadri; Derek C Angus; Robert L Danner; Anthony E Fiore; John A Jernigan; Greg S Martin; Edward Septimus; David K Warren; Anita Karcz; Christina Chan; John T Menchaca; Rui Wang; Susan Gruber; Michael Klompas Journal: JAMA Date: 2017-10-03 Impact factor: 56.272
Authors: Russell B Hawkins; Steven L Raymond; Julie A Stortz; Hiroyuki Horiguchi; Scott C Brakenridge; Anna Gardner; Philip A Efron; Azra Bihorac; Mark Segal; Frederick A Moore; Lyle L Moldawer Journal: Front Immunol Date: 2018-07-02 Impact factor: 7.561
Authors: Michael C Cox; Scott C Brakenridge; Julie A Stortz; Russell B Hawkins; Dijoa B Darden; Gabriela L Ghita; Alicia M Mohr; Lyle L Moldawer; Philip A Efron; Frederick A Moore Journal: Am J Surg Date: 2020-07-25 Impact factor: 2.565